Related Topics >> FDA | Abbott Labs | Humira

SPOTLIGHT: FDA expands Humira approval

November 13, 2006 — 8:01pm ET

Related Stories

Tools

The FDA has expanded its approval of Abbott Laboratories' Humira for psoriatic arthritis. The drug can be used to inhibit structural damage and improve physical activity in patients. The agency approved Humira for psoriatic arthritis a year ago. Report

Be the first to comment

More stories about FDA Abbott Labs Humira

Comments

Post new comment

Paid Research Reports

RNA therapy: the next big thing after monoclonal antibodies?
Biotech M&A Strategies: Deal assessments, trends and future prospects
The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
Sales Force Effectiveness
Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage

More Research Reports >>